Microglia and astrocytes play crucial roles in Alzheimer's Disease (AD) and dementia. Microglia, the brain's resident immune cells, become activated in response to beta-amyloid plaques, hallmark features of AD, attempting to clear them but often contributing to neuroinflammation and neuronal damage. Dysfunctional microglia exacerbate disease progression by failing to properly regulate inflammation or clear debris.
Astrocytes, another type of glial cell, provide essential support to neurons and help maintain the blood-brain barrier. In AD, astrocytes react to pathological changes by altering their functions, such as releasing inflammatory cytokines or changing their ability to buffer neurotransmitters and ions. These alterations disrupt brain homeostasis and contribute to cognitive decline.
Understanding the intricate roles of microglia and astrocytes in neurodegenerative diseases like AD is crucial for developing targeted therapies that mitigate neuroinflammation while preserving brain function and structure.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States